Cvs Health (CVS) Non-Current Deferred Tax Liability (2009 - 2026)

Cvs Health's Non-Current Deferred Tax Liability history runs 18 years deep, the most recent figure standing at $3.8 billion for Q1 2026.

• Quarterly Non-Current Deferred Tax Liability rose 2.92% year-over-year to $3.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 billion (up 2.92% YoY) and the FY2025 annual result came in at $3.8 billion, down 66.42% from the prior year.
• Non-Current Deferred Tax Liability was $3.8 billion for Q1 2026 at Cvs Health, down from $3.8 billion in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $11.4 billion in Q4 2024 and bottomed at $3.5 billion in Q3 2022.
• A 5-year average of $4.6 billion and a median of $4.1 billion in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability soared 164.74% — and 2025, when it plunged 66.42%.
• Cvs Health's Non-Current Deferred Tax Liability stood at $4.0 billion in 2022, then advanced by 7.35% to $4.3 billion in 2023, then surged by 164.74% to $11.4 billion in 2024, then plunged by 66.42% to $3.8 billion in 2025, then decreased by 1.59% to $3.8 billion in 2026.
• Business Quant data shows CVS's Non-Current Deferred Tax Liability at $3.8 billion in Q1 2026, $3.8 billion in Q4 2025, and $3.5 billion in Q3 2025.